OCULAR THERAPEUTIX, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OCULAR THERAPEUTIX, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 3.72M shares, a 19.56% increase from fiscal 2024.
- OCULAR THERAPEUTIX, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 3.11M shares, a 2092.98% increase from fiscal 2023.
- OCULAR THERAPEUTIX, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 141.95K shares, a 3.24% increase from fiscal 2022.
- OCULAR THERAPEUTIX, INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 137.50K shares, a 77.04% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 3.72M shares 10-K · filed 2026-02-05 | |
| 2024-12-31 | 3.11M shares 10-K · filed 2025-03-03 | |
| 2023-12-31 | 141.95K shares 10-K · filed 2024-03-11 | |
| 2022-12-31 | 137.50K shares 10-K · filed 2023-03-06 | |
| 2021-12-31 | 598.92K shares 10-K · filed 2022-02-28 | |
| 2020-12-31 | 567.78K shares 10-K · filed 2021-03-11 | |
| 2019-12-31 | 28.58K shares 10-K · filed 2020-03-12 | |
| 2018-12-31 | 182.26K shares 10-K · filed 2019-03-07 | |
| 2017-12-31 | 220.52K shares 10-K · filed 2018-03-08 | |
| 2016-12-31 | 105.11K shares 10-K · filed 2017-03-10 | |
| 2015-12-31 | 141.85K shares 10-K · filed 2016-03-10 | |
| 2014-12-31 | 44.09K shares 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |